QT Imaging Holdings to Attend Radiological Society of North America 2024 Annual Meeting
Dr. Bilal Malik will deliver a presentation on December 4th during the 9:30 am session on Breast Ultrasound Techniques. His talk titled: “Assessing Non-inferiority of quantitative transmission (QT) ultrasound imaging compared with digital breast tomosynthesis (DBT): Results from multi-reader, multi-case (MRMC) observer study”, will highlight the comparative performance of QTI’s and DBT technologies in breast imaging, with an emphasis on findings from the MRMC study that support the potential of QTI as a reliable and effective alternative for breast cancer screening and diagnosis. “Our study represents a major milestone in breast imaging,” said Dr. Malik. “By demonstrating that QTI performs on par with DBT, we are opening the door to safe, more accessible, and patient-friendly diagnostic option.” Additional details will be shared during the presentation.
About QT Imaging Holding, Inc.
QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the company’s website at www.qtimaging.com.
Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241121664478/en/
For media inquiries, please contact:
Susan Schaffler
Head of Communications
Susan.Schaffler@qtimaging.com
Stas Budagov
Chief Financial Officer
Stas.Budagov@qtimaging.com
Source: QT Imaging Holdings, Inc.
